Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by wexworthon Jul 28, 2020 2:26pm

150 Views

Post# 31332356

RE:RE:New Tweet from SBM

Yeah, I pointed that out earlier but our village idiot shot it down.

People will use the product whatever way they want, but correct, it is officially purposed as such.

When we hear about a solid track for 1067 extraordinary strength, I think the challenge then will be to keep up with production demand for asian markets. They will need extra supply capacity.

Bullboard Posts

Canada Nickel unveils second of seven resources planned by mid-2025